Composition, form of production and packaging
? Ointment for external use 5% homogeneous, white.
100 g
deproteinized hemoderate from calves' blood 5 ml,
which corresponds to a dry matter content of 200 mg
Excipients: paraffin white - 66.0 g, cholesterol (cholesterol) - 0.10 g, cetyl alcohol - 3.50 g, methyl parahydroxybenzoate - 0.16 g, propyl parahydroxybenzoate - 0.02 g, purified water - 30.02.
20 g - aluminum tubes (1) - cardboard boxes.
30 g - aluminum tubes (1) - cardboard boxes.
50 g - aluminum tubes (1) - cardboard boxes.
100 g - aluminum tubes (1) - cardboard boxes.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2014.
PHARMACHOLOGIC EFFECT
Actovegin - antihypoxant, activates the metabolism of glucose and oxygen.
Actovegin causes an increase in cellular energy metabolism. Its activity is confirmed by increased consumption and increased utilization of glucose and oxygen by cells. These two effects are conjugate, they cause an increase in the metabolism of ATP and, consequently, increase energy metabolism. The result is the stimulation and acceleration of the healing process, characterized by increased energy consumption.
INDICATIONS
- Wounds and inflammatory diseases of the skin and mucous membranes, such as: solar, thermal, chemical burns in the acute stage, cuts of the skin, abrasions, scratches, cracks;
- to improve tissue regeneration after burns, incl. after burning with boiling liquid or steam;
- ulcers of varicose origin or other soaking ulcers;
- for prophylaxis and treatment of decubitus;
- for the prevention and treatment of reactions from the skin and mucous membranes caused by exposure to radiation.
DOSING MODE
The course of treatment is at least 12 days and continues throughout the period of active regeneration. Multiplicity of application - at least 2 times / day.
Ulcers, wounds and inflammatory diseases of the skin and mucous membranes: as a rule, as a last link in a phased "three-step treatment" with Actovegin 20% in the form of a gel and 5% cream, Actovegin 5% ointment is applied in a thin layer.
For the prevention of decubitus, the ointment is rubbed into the skin in high-risk areas.
To prevent the occurrence of radiation damage, Actovegin 5% ointment is applied a thin layer immediately after radiation therapy and in intervals between sessions.
If there is no or insufficient effect from the application of 5% of Actovegin in the form of an ointment, you should consult a doctor.
SIDE EFFECT
Usually the drug is well tolerated.
In patients who have a history of hypersensitivity reactions, in rare cases, allergic reactions may develop.
CONTRAINDICATIONS
Hypersensitivity to the drug Actovegin or similar drugs.
PREGNANCY AND LACTATION
Use in pregnancy and lactation allowed.
DRUG INTERACTION
Interaction with other drugs is currently unknown.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
Keep the drug out of reach of children at a temperature of no higher than 25 В° C.
Shelf life - 5 years. Do not use after expiry date.
